Alcon Issues First Corporate Responsibility Report as Independent Company
July 15 2020 - 9:00AM
Business Wire
Alcon (SIX/NYSE:ALC), the global leader in eye care dedicated to
helping people see brilliantly, today released its inaugural
Corporate Responsibility (CR)
report. The CR report, the Company’s first as an independent,
publicly traded company, describes Alcon’s corporate responsibility
strategy, and focuses on four key areas: benefitting customers and
patients, caring for the environment, winning in the workplace, and
working with integrity.
“Our mission of helping people see brilliantly is rooted in
enabling all stakeholders to live life to the fullest, and we take
our stewardship role very seriously,” said David Endicott, Chief
Executive Officer, Alcon. “We are deeply committed to our
customers, patients, associates and the communities where we live
and work, and our inaugural report reflects that commitment and
serves as the roadmap for our corporate responsibility
journey.”
Highlights of the report include:
Benefitting Customers & Patients
- 58 major market product approvals in 2019
- 4,000+ doctors enrolled in Alcon’s Phaco Development program,
which aims to bring cataract surgery using Alcon’s innovative
technologies to underserved areas
- 400,000 patients served per year through programs supported by
Alcon’s foundation, Alcon Cares, which donates equipment and
products for medical missions and capacity building
- 4,000 volunteers during Alcon’s first ‘Alcon in Action’
community service day
- No FDA-initiated recalls or serious findings from regulatory
authorities in the last 5 years
Caring for Our Environment
- 94% of sites certified to ISO 14001 standards
- 23 energy-saving projects completed in 2019 resulting in an
estimated more than 19,000 gigajoules in savings and the avoidance
of nearly 3,800 tons of carbon dioxide equivalent greenhouse
emissions
- 12 water-saving projects implemented in 2019 resulting in an
estimated 75 megaliters in water savings
Winning in the Workplace
- A diverse workforce of more than 20,000 associates, of which
approximately half are female
- In the United States, 44% of our associates have
self-identified as ethnically diverse
- Safe working conditions, with 0.10 Lost Time Incident Rate
(LTIR)
Working with Integrity
- 98%+ completion rate for Alcon’s Code of Business Conduct
training
- A Third Party Code of Conduct, covering numerous environment,
social governance (ESG) topics including labor rights, health and
safety, environment, animal welfare, anti-bribery and fair
competition, data privacy and information protection, conflict
minerals, management systems, and trade sanctions
“We’ve been actively engaged in ESG initiatives over our 70+
years in ophthalmology and optometry. While some of our ESG
initiatives are more developed, others are still in early stages,”
Mr. Endicott continued. “Over the course of the coming years, we
will gather and benchmark data to further inform and evolve our
understanding and improve of our performance in these areas in
these areas.”
In 2020, the Alcon Board of Directors established the Governance
and Nomination Committee to formally oversee Alcon’s ESG efforts.
With oversight by the Board, Alcon also created an ESG Executive
Steering Committee comprised of senior executives to identify and
manage Alcon’s environmental and social impacts, as well as to
develop the CR report.
Methodology
Alcon conducted a materiality assessment that identified
material and relevant ESG priorities after extensive interviews
with subject matter experts, business leaders and internal and
external stakeholders. The CR report is aligned with the framework
created by the Sustainability Accounting Standards Board (SASB) and
the Global Reporting Initiative (GRI). Alcon’s CR report details
the governance and management approach of these identified key
areas, and provides historical data to select metrics in accordance
with SASB and GRI reporting requirements.
The CR report can be found on Alcon’s investor relations site,
investor.alcon.com.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning more than seven decades, we offer the
broadest portfolio of products to enhance sight and improve
people’s lives. Our Surgical and Vision Care products touch the
lives of more than 260 million people in over 140 countries each
year living with conditions like cataracts, glaucoma, retinal
diseases and refractive errors. Our more than 20,000 associates are
enhancing the quality of life through innovative products,
partnerships with eye care professionals and programs that advance
access to quality eye care. Learn more at www.alcon.com.
Connect with us on
Facebook
LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200715005494/en/
Investor Relations Christina
Cheng + 41 589 112 110 (Geneva) + 1 817 615 2789 (Fort Worth)
investor.relations@alcon.com Media
Relations Steven Smith + 41 589 112 111 (Geneva) + 1 213
280 9974 (Fort Worth) globalmedia.relations@alcon.com
Alcon (NYSE:ALC)
Historical Stock Chart
From May 2024 to Jun 2024
Alcon (NYSE:ALC)
Historical Stock Chart
From Jun 2023 to Jun 2024